** Alignment Healthcare's ALHC.O shares down 3% at $15.97 on Thurs after General Atlantic reduces its stake in the health insurer
** Orange, California-based firm late Weds disclosed proposed sale of 13.46 mln shares by the private equity firm in Rule 144/unregistered block via Morgan Stanley
** The block was priced at $16.08, a 2.2% discount to stock's last close, thefly.com reported, for ~$216.4 mln gross proceeds
** Prior to the sale, General Atlantic owned ~44 mln ALHC shares for ~22% stake
** ALHC has ~198 mln shares outstanding for ~$3.1 bln market cap
** Even with the decline on the session, shares up ~42% YTD
** In Jul, co reported Q2 rev of $1 bln, topping consensus, and raised its annual rev forecast to $3.89-$3.91 bln from prior outlook of $3.77-$3.82 bln
** Of 12 analysts covering ALHC, 9 rate the stock "strong buy" or "buy", 3 rate "hold"; median PT is $20, per LSEG data
(Lance Tupper is a Reuters market analyst. The views expressed are his own)
((lance.tupper@thomsonreuters.com))